Lv11
30 积分 2021-09-26 加入
Neoadjuvant Chemotherapy in Resectable Biliary Tract Cancer: A Systematic Review and Metanalysis
3小时前
待确认
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
3小时前
已完结
Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials
5小时前
求助中
A Model for Decoding Resistance in Precision Oncology: Acquired Resistance to FGFR inhibitors in Cholangiocarcinoma
2个月前
已完结
Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients
3个月前
已完结
NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
4个月前
已完结
Insights Into Vepdegestrant (ARV‐471): The First‐in‐Class Estrogen Receptor Proteolysis‐Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
4个月前
已完结
Disposition and Absolute Bioavailability of Orally Administered Orforglipron in Healthy Participants
8个月前
已完结
Polypharmacology – Foe or Friend?
9个月前
已完结
Translational Pharmacokinetic-Pharmacodynamic Modeling for an Orally Available Novel Inhibitor of Epigenetic Regulator Enhancer of Zeste Homolog 2
1年前
已完结
皖公网安备34019202002308
